Antimicrobial Agents and Chemotherapy · 2011 · 73 citations · 12 references
Life SciencesMicrobiologyMolecular BiologyBacteriologyEnzymologyStructural BiologyBeta-lactam ResistanceCarbapenem ResistanceProtein StructureAcinetobacter Baumannii ResistanceAmpc Beta-lactamase-mediated ResistanceAmpc Beta-lactamasesCarbapenem AntibioticsCarbapenem-hydrolyzing EnzymesCarbapenemase EnzymesExtended-spectrum Beta-lactamasesProtein Conformational Changes
ADC-56, a novel extended-spectrum AmpC (ESAC) β-lactamase, was identified in an Acinetobacter baumannii clinical isolate. ADC-56 possessed an R148Q change compared with its putative progenitor, ADC-30, which enabled it to hydrolyze cefepime. Molecular modeling suggested that R148 interacted with Q267, E272, and I291 through a hydrogen bond network which constrained the H-10 helix. This permitted cefepime to undergo conformational changes in the active site, with the carboxyl interacting with R340, likely allowing for better binding and turnover.
12
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Konstantin Arnold, Lorenza Bordoli, Jürgen Kopp et al. · Bioinformatics · 2005 · 7.1K citations · Full text
Kristine M. Hujer, Nashaat S. Hamza, Andrea M. Hujer et al. · Antimicrobial Agents and Chemotherapy · 2005 · 147 citations